NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

EX,

DCVax-L's approval is imminent no matter what the shorts are desperately doing.

Keep in mind at least 600 GBM patients receiving DCVax-L. There will be huge amount of real world data illustrating the enormous efficacy of DCVax-L. Recall what Professor Ashkan was confident that three shots was enough to prime the immune system. Most patients would have more than three shots. Just cannot imagine how good the results would be. It is no brainer that any RA on this planet would grant the approval.